127 related articles for article (PubMed ID: 35358111)
1. Association Between the Intracellular Tacrolimus Concentration in CD3 + T Lymphocytes and CD14 + Monocytes and Acute Kidney Transplant Rejection.
Udomkarnjananun S; Francke MI; Dieterich M; van de Velde D; Verhoeven JGHP; Boer K; Clahsen-Van Groningen MC; De Winter BCM; Baan CC; Hesselink DA
Ther Drug Monit; 2022 Oct; 44(5):625-632. PubMed ID: 35358111
[TBL] [Abstract][Full Text] [Related]
2. Monitoring intracellular tacrolimus concentrations and its relationship with rejection in the early phase after renal transplantation.
Francke MI; Andrews LM; Lan Le H; van de Velde D; Dieterich M; Udomkarnjananun S; Clahsen-van Groningen MC; Baan CC; van Gelder T; de Winter BCM; Hesselink DA
Clin Biochem; 2022 Mar; 101():9-15. PubMed ID: 34890583
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney Transplantation.
Klaasen RA; Bergan S; Bremer S; Daleq L; Andersen AM; Midtvedt K; Skauby MH; Vethe NT
Ther Drug Monit; 2018 Oct; 40(5):558-566. PubMed ID: 30086087
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein, FK-binding Protein-12, and the Intracellular Tacrolimus Concentration in T-lymphocytes and Monocytes of Kidney Transplant Recipients.
Udomkarnjananun S; Francke MI; Dieterich M; van De Velde D; Litjens NHR; Boer K; De Winter BCM; Baan CC; Hesselink DA
Transplantation; 2023 Feb; 107(2):382-391. PubMed ID: 36070572
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients.
Lemaitre F; Antignac M; Fernandez C
Clin Biochem; 2013 Oct; 46(15):1538-41. PubMed ID: 23454394
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients.
Wang XH; Shao K; An HM; Zhai XH; Zhou PJ; Chen B
Eur J Clin Pharmacol; 2022 Aug; 78(8):1261-1272. PubMed ID: 35536394
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic Monitoring of Tacrolimus-Based Immunosuppression in CD14+ Monocytes After Kidney Transplantation.
Kannegieter NM; Hesselink DA; Dieterich M; de Graav GN; Kraaijeveld R; Rowshani AT; Leenen PJM; Baan CC
Ther Drug Monit; 2017 Oct; 39(5):463-471. PubMed ID: 28640063
[TBL] [Abstract][Full Text] [Related]
8. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
Włodarczyk Z; Wałaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradsky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Nagy KK; Hickey D
Ann Transplant; 2002; 7(3):28-31. PubMed ID: 12465429
[TBL] [Abstract][Full Text] [Related]
9. Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients.
Francke MI; Hesselink DA; Li Y; Koch BCP; de Wit LEA; van Schaik RHN; Yang L; Baan CC; van Gelder T; de Winter BCM
Br J Clin Pharmacol; 2021 Apr; 87(4):1918-1929. PubMed ID: 33025649
[TBL] [Abstract][Full Text] [Related]
10. Intracellular tacrolimus concentration correlates with impaired renal function through regulation of the IS-AHR-ABC transporter in peripheral blood mononuclear cells.
Guo P; Zhang R; Zhou J; Li P; Liu Y; Shi S
Int Immunopharmacol; 2024 Jan; 126():111233. PubMed ID: 37979449
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus diffusion across the peripheral mononuclear blood cell membrane: impact of drug transporters.
Tron C; Allard M; Petitcollin A; Ferrand-Sorre MJ; Verdier MC; Querzerho-Raguideau J; Blanchet B; Le Priol J; Roussel M; Deugnier Y; Bellissant E; Lemaitre F
Fundam Clin Pharmacol; 2019 Feb; 33(1):113-121. PubMed ID: 30203853
[TBL] [Abstract][Full Text] [Related]
12. Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study.
Capron A; Lerut J; Latinne D; Rahier J; Haufroid V; Wallemacq P
Transpl Int; 2012 Jan; 25(1):41-7. PubMed ID: 21981711
[TBL] [Abstract][Full Text] [Related]
13. Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients.
Tawhari I; Hallak P; Bin S; Yamani F; Safar-Boueri M; Irshad A; Leventhal J; Ansari MJ; Cravedi P; Gallon L
Front Immunol; 2022; 13():1096881. PubMed ID: 36601111
[TBL] [Abstract][Full Text] [Related]
14. Is There a Temporal Relationship Between Trough Whole Blood Tacrolimus Concentration and Acute Rejection in the First 14 Days After Kidney Transplantation?
Hu R; Barratt DT; Coller JK; Sallustio BC; Somogyi AA
Ther Drug Monit; 2019 Aug; 41(4):528-532. PubMed ID: 31259882
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
[TBL] [Abstract][Full Text] [Related]
16. Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function.
Han SS; Yang SH; Kim MC; Cho JY; Min SI; Lee JP; Kim DK; Ha J; Kim YS
PLoS One; 2016; 11(4):e0153491. PubMed ID: 27082871
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of tacrolimus on p38 mitogen-activated protein kinase signaling in kidney transplant recipients measured by whole-blood phosphospecific flow cytometry.
Vafadari R; Hesselink DA; Cadogan MM; Weimar W; Baan CC
Transplantation; 2012 Jun; 93(12):1245-51. PubMed ID: 22643331
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic-Whole blood and intracellular pharmacokinetic-Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients.
Tron C; Woillard JB; Houssel-Debry P; David V; Jezequel C; Rayar M; Balakirouchenane D; Blanchet B; Debord J; Petitcollin A; Roussel M; Verdier MC; Bellissant E; Lemaitre F
PLoS One; 2020; 15(3):e0230195. PubMed ID: 32163483
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells.
Lemaitre F; Blanchet B; Latournerie M; Antignac M; Houssel-Debry P; Verdier MC; Dermu M; Camus C; Le Priol J; Roussel M; Zheng Y; Fillatre P; Curis E; Bellissant E; Boudjema K; Fernandez C
Clin Biochem; 2015 Apr; 48(6):406-11. PubMed ID: 25562187
[TBL] [Abstract][Full Text] [Related]
20. Can the Toll-like receptors 4 expression in peripheral blood mononuclear cells help assess the effectiveness of immunosuppression and the chance of a future good renal transplant function?
Zmonarski SC; Madziarska K; Golebiowski T; Banasik M; Mazanowska O; Madziarski M; Krajewska M
Transpl Immunol; 2019 Apr; 53():43-50. PubMed ID: 30592973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
